An Artemisinin-Derived Dimer Has Highly Potent Anti-Cytomegalovirus (CMV) and Anti-Cancer Activities
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An Artemisinin-Derived Dimer Has Highly Potent Anti-Cytomegalovirus (CMV) and Anti-Cancer Activities
Authors
Keywords
-
Journal
PLoS One
Volume 6, Issue 8, Pages e24334
Publisher
Public Library of Science (PLoS)
Online
2011-09-01
DOI
10.1371/journal.pone.0024334
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recombinant luciferase-expressing human cytomegalovirus (CMV) for evaluation of CMV inhibitors
- (2011) Ran He et al. Virology Journal
- A single, low, oral dose of a 5-carbon-linked trioxane dimer orthoester plus mefloquine cures malaria-infected mice
- (2010) Deuk Kyu Moon et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The multi-targeted kinase inhibitor sorafenib inhibits human cytomegalovirus replication
- (2010) Martin Michaelis et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Cytotoxicity of Artesunic Acid Homo- and Heterodimer Molecules toward Sensitive and Multidrug-Resistant CCRF-CEM Leukemia Cells
- (2010) Cindy Horwedel et al. JOURNAL OF MEDICINAL CHEMISTRY
- Artemisinin-Derived Dimers Have Greatly Improved Anti-Cytomegalovirus Activity Compared to Artemisinin Monomers
- (2010) Ravit Arav-Boger et al. PLoS One
- Antiviral treatment of cytomegalovirus infection and resistant strains
- (2009) Andreas Schreiber et al. EXPERT OPINION ON PHARMACOTHERAPY
- Anticancer activities of artemisinin and its bioactive derivatives
- (2009) Gary L. Firestone et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Malaria-Infected Mice Are Cured by a Single Oral Dose of New Dimeric Trioxane Sulfones Which Are Also Selectively and Powerfully Cytotoxic to Cancer Cells
- (2009) Andrew S. Rosenthal et al. JOURNAL OF MEDICINAL CHEMISTRY
- Malaria-Infected Mice Live until at Least Day 30 after a New Monomeric Trioxane Combined with Mefloquine Are Administered Together in a Single Low Oral Dose†
- (2009) Lauren E. Woodard et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mortality Associated with Resistant Cytomegalovirus among Patients with Cytomegalovirus Retinitis and AIDS
- (2009) Douglas A. Jabs et al. OPHTHALMOLOGY
- Accumulation of artemisinin trioxane derivatives within neutral lipids of Plasmodium falciparum malaria parasites is endoperoxide-dependent
- (2008) Carmony L. Hartwig et al. BIOCHEMICAL PHARMACOLOGY
- The Antiviral Activities of Artemisinin and Artesunate
- (2008) Thomas Efferth et al. CLINICAL INFECTIOUS DISEASES
- Reactivation of Cytomegalovirus Infection in Critically Ill Immunocompetent Patients—Reply
- (2008) Ajit P. Limaye JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs
- (2008) Lin Shen et al. NATURE MEDICINE
- Effect of artemisinins and other endoperoxides on nitric oxide-related signaling pathway in RAW 264.7 mouse macrophage cells
- (2008) V. Badireenath Konkimalla et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
- Qinghaosu (Artemisinin): The Price of Success
- (2008) N. J. White SCIENCE
- Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma
- (2007) Duane A. Mitchell et al. NEURO-ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started